The Medicine Forum

Article Title

Cidofovir and intravenous immunoglobulin for treatment of BK polyomarivus nephropathy

Authors

Anita Mehrotra, MD, Thomas Jefferson UniversityFollow
Rajani Dinavahi, MD, Thomas Jefferson UniversityFollow
George C. Francos, MD, Thomas Jefferson UniversityFollow

Abstract

BK polyomavirus nephropathy (BKN) is an important cause of renal allograft dysfunction and loss. The mainstay of therapy is reduced immunosuppression, but definitive protocols for the diagnosis and management remain to be defined. We report here a retrospective analysis of 6 patients with BKN treated with cidofovir and intravenous immunoglobulin(IVIG).

Recommended Citation

Mehrotra, MD, Anita; Dinavahi, MD, Rajani; and Francos, MD, George C. (2006) "Cidofovir and intravenous immunoglobulin for treatment of BK polyomarivus nephropathy," The Medicine Forum: Vol. 8, Article 5.
DOI: https://doi.org/10.29046/TMF.008.1.004
Available at: https://jdc.jefferson.edu/tmf/vol8/iss1/5